yeah it's certainly no ordinary stock dolcevita, and it would appear there is much this equities analyst does not know about msb - their report should be amusing.
On another matter, I'll be interested to see if "they" can still keep the sp under $10 after November 14. As we know; 17,000 international cardiovascular specialists are expected to attend the American Heart Association annual conference in Orlando, Florida - where Dr Emerson C. Perin, Director of Research in Cardiovascular Medicine and Medical Director, Stem Cell Center, Texas Heart Institute, Houston will present Revascor trial results.
To quote Professor Itescu: "This forum provides an excellent opportunity for a wide audience of cardiovascular experts to be exposed to Mesoblast's proprietary cutting-edge technology and our robust clinical results."
Go The Blast! :)
the next mesoblast, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
-0.070(7.22%) |
Mkt cap ! $1.033B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 95.0¢ | 90.0¢ | $7.835M | 8.540M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 228366 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 215513 | 43 |
View Market Depth
| Last trade - 15.17pm 05/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |